Kyverna Therapeutics Inc.
KYTX | NASDAQ
$7.12
-$0.01 (-0.14%)
At close: Sep 21, 2026, 4:00 PM ET
$7.20
+$0.08 (+1.12%)
Pre-market:
Sep 22, 2026, 8:15 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
Net Income | -161.31M | -127.48M | -60.37M | -28.89M | -26.35M |
Depreciation & Amortization | 1.8M | 2.13M | 1.71M | 1.05M | 586K |
Stock-Based Compensation | 10.08M | 8.36M | 2.22M | 929K | 7.25M |
Other Working Capital | -1.62M | 7.12M | -659K | -11M | -4.5M |
Other Non-Cash Items | -3.21M | -5.12M | 605K | 1.13M | 850K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.08M | 7.86M | 3.42M | -10.33M | -4.49M |
Operating Cash Flow | -153.71M | -114.25M | -52.41M | -36.11M | -22.16M |
Capital Expenditures | -5K | -2.21M | -621K | -768K | -1.29M |
Cash Acquisitions | 70K | n/a | n/a | n/a | n/a |
Purchase of Investments | -364.62M | -490M | -54.85M | -56.5M | n/a |
Sales Maturities Of Investments | 398.81M | 323.64M | 46.68M | 43.17M | n/a |
Other Investing Acitivies | 5.76M | 7.66M | n/a | n/a | n/a |
Investing Cash Flow | 40.02M | -160.9M | -8.79M | -14.1M | -1.29M |
Debt Repayment | 23.89M | -956K | -781K | -249K | -41K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -144K | -3.1M | -1.65M | n/a | n/a |
Financial Cash Flow | 141.17M | 337.11M | 58.12M | 11.88M | 72.52M |
Net Cash Flow | 27.47M | 61.96M | -3.08M | -38.33M | 49.08M |
Free Cash Flow | -153.72M | -116.46M | -53.03M | -36.88M | -23.44M |
Adj. Free Cash Flow | -163.8M | -124.81M | -55.25M | -37.81M | -30.69M |
Maintenance CapEx | -5K | -2.21M | -621K | n/a | -1.29M |
Growth CapEx | n/a | n/a | n/a | -768K | n/a |
Owner Earnings | -153.72M | -116.46M | -53.03M | -36.11M | -23.44M |
Add to Watchlist
Select watchlists to add or remove KYTX